Home Patent Forecast® Sectors Log In   Contact  
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. For full access, try it free at any time.        

Cannabis: Medical

Zynerba Pharmaceuticals, Inc.


Zynerba is developing transdermal cannabis drugs and prodrugs for the treatment of Fragile X syndrome, autism spectrum disorder, developmental and epileptic encephalopathies, and 22q. As of July 2021, its patented Zygel™ topical CBD gel has not been approved by government agencies in the US. 

News and Insights

Zynerba Pharmaceuticals, Inc. Owned Patent Documents in this Patent Forecast
Loading Documents...